USCIS I-693: Why Shingrix Won’t Replace Varivax
Varivax prevents chickenpox (varicella) and is the vaccine USCIS accepts as proof of varicella immunity on Form I-693. Shingrix prevents shingles in adults and cannot substitute for Varivax on your immigration paperwork. They’re built on different vaccine technologies, target different diseases at different life stages, and mixing them up on an I-693 exam can stall a green card application for weeks.
TL;DR:
- Varivax is the only approved vaccine for proving varicella immunity on USCIS Form I-693, while Shingrix cannot substitute for it even though it prevents shingles.
- Live Varivax requires storage in frozen conditions and is contraindicated during pregnancy or in immunocompromised individuals, unlike non-live Shingrix, which is shelf-stable and safe for those groups.
- A documented two-dose Varivax vaccination record or a positive varicella titer is generally accepted as proof of immunity, reducing the need for additional shots or blood tests before the exam.
- Shingrix is recommended for adults 50 and older or immunocompromised adults younger than that, but it does not count towards varicella immunity documentation for USCIS purposes.
- Civil surgeons routinely handle vaccination, titer testing, and documentation during the same appointment to prevent delays in immigration applications.
Table of Contents
- Varivax vs Shingrix Comparison at a Glance
- Varivax: Licensing, Schedule, and Its Role on Form I-693
- Shingrix: Who Needs It and What to Expect
- Side Effects, Contraindications, and Vaccine Spacing Rules
- USCIS Form I-693: Documenting Varicella Immunity Correctly
- What to Do Before Your Immigration Medical Exam
- Storage, Handling, and Why It Affects Your Appointment
- Does Getting One Vaccine Affect the Other?
- If You Already Had Chickenpox, Do You Still Need Shingrix?
- Cost Considerations and Insurance Coverage
- How Long Does Protection Actually Last?
- Clinic Perspective: What We See Behind the Scenes
- Get Your I-693 Exam and Vaccine Review Done Right the First Time
- Sources
- FAQ
Varivax vs Shingrix Comparison at a Glance
The confusion between these two vaccines makes sense. Both guard against the same virus family, varicella zoster, but at opposite ends of that virus’s life cycle in the body. Varivax stops the initial infection. Shingrix stops that dormant virus from reactivating decades later as shingles.
Here’s how they actually break down:
- Disease prevented: Varivax targets chickenpox (primary varicella infection); Shingrix targets shingles (herpes zoster reactivation) and its nerve pain complication, postherpetic neuralgia.
- Vaccine type: Varivax is a live-attenuated varicella vaccine, meaning it contains a weakened live virus; Shingrix is a recombinant non-live vaccine built from a single viral protein plus an immune-boosting adjuvant.
- Approved ages: Varivax is licensed from 12 months of age; Shingrix is recommended for adults 50 and older, plus adults 19 and older who are immunocompromised.
- Dosing schedule: Varivax is a 2-dose series (timing depends on age); Shingrix is a 2-dose series given 2 to 6 months apart for most healthy adults.
- Efficacy: Two doses of varicella vaccine run roughly 90% effective at preventing chickenpox; Shingrix trials showed about 97% efficacy against shingles in adults 50 to 69.
- Common side effects: Both cause sore arms and mild fatigue; Shingrix reactions tend to be more noticeable but short-lived.
Varivax: Licensing, Schedule, and Its Role on Form I-693
Varivax is a live-attenuated vaccine that has been part of the routine U.S. childhood immunization schedule for decades, typically given at 12 to 15 months and again at 4 to 6 years. Adults and adolescents who never had chickenpox or never got vaccinated need a 2-dose catch-up series, spaced 4 to 8 weeks apart.
Because it’s a live vaccine, Varivax carries a few real restrictions:
- It’s not given during pregnancy.
- It’s avoided in people with significant immunocompromise.
- A small percentage of recipients develop a mild vaccine-related rash, which sometimes requires brief contact precautions around newborns or pregnant household members.
For immigration purposes, this matters directly. USCIS requires documented proof of varicella immunity for Form I-693, and when an applicant has no vaccine records and no reliable history of having had chickenpox, a civil surgeon can administer Varivax during the exam itself.
Pro Tip: Dig through old school or pediatrician records before your exam. A single old immunization card showing two varicella doses can save you an extra visit, a blood draw, or a repeat vaccination you didn’t actually need.
Shingrix: Who Needs It and What to Expect
Shingrix is the current U.S. standard for shingles prevention, recommended by the CDC for adults 50 and older, and separately for adults 19 and older who face higher shingles risk due to immunosuppression from a condition or a medication. It’s a non-live, recombinant vaccine, so it doesn’t carry the pregnancy and immune-status restrictions that come with Varivax.
The standard schedule is 2 doses spaced 2 to 6 months apart for most healthy adults. People with weakened immune systems sometimes qualify for a shorter interval between doses, at a clinician’s discretion.
A few practical points worth knowing before your appointment:
- Shingrix does not require confirming a prior chickenpox history before you get it, since it isn’t a chickenpox vaccine.
- Reactogenicity is common: expect a sore arm, possible fatigue, muscle aches, or a mild fever, usually resolving within 72 hours.
- It can be given while taking antiviral medications, which matters for people managing other chronic conditions.
- It does nothing to prevent a first-time chickenpox infection and was never designed to.
Side Effects, Contraindications, and Vaccine Spacing Rules
Both vaccines cause the usual injection-site soreness and mild systemic symptoms, and in most people those fade within one to three days. The real differences show up in who should avoid each one.
Varivax, being live, is off the table during pregnancy and for most people with significant immune suppression. Shingrix, being non-live, is actually approved specifically for many of the immunocompromised adults who can’t safely receive Varivax.
Clinical data behind Shingrix show about 97% efficacy against shingles in adults 50 to 69, one of the higher efficacy rates recorded for an adult vaccine.
One scheduling detail trips people up: if a live vaccine like Varivax isn’t given on the same day as another live vaccine, a 28-day spacing rule applies between the two. And if you have a rough reaction after your first Shingrix dose, CDC guidance still calls for completing the second dose. Skipping it leaves you with partial protection at best.
USCIS Form I-693: Documenting Varicella Immunity Correctly
Immigration applicants run into more confusion here than anywhere else in this comparison. USCIS requires documented evidence of varicella immunity for Form I-693, full stop. Shingrix does not count toward this requirement under any circumstance, because it protects against shingles, not chickenpox, and civil surgeons are instructed accordingly.
Acceptable evidence generally falls into one of these categories:
- Documented 2-dose Varivax vaccination record, ideally with dates, from a school, pediatrician, or prior physician.
- Laboratory evidence of immunity, meaning a blood test (titer) showing you’re already immune, whether from prior infection or past vaccination.
- Reliable, verified history in the limited cases where a civil surgeon’s own records or documented provider history support it. A vague verbal recollection of “I think I had chickenpox as a kid” usually isn’t enough on its own.
When none of that exists, the civil surgeon typically orders a titer or administers Varivax on the spot, following the standard 2-dose adult catch-up schedule.
Pro Tip: A varicella titer often runs somewhere around $50 to $70 depending on the lab, which can work out cheaper than two rounds of vaccination if you’re fairly confident you already had chickenpox as a child. Commercial assays do vary somewhat in sensitivity, so a borderline result sometimes still leads to vaccination anyway.
What to Do Before Your Immigration Medical Exam
Matching the right vaccine to the right situation comes down to a handful of common scenarios.
- Routine child immunization: Varivax, on the standard pediatric schedule, no I-693 considerations involved.
- Adult 50 or older, or younger with an immune-compromising condition: Shingrix, for shingles prevention, unrelated to any immigration paperwork.
- Immigration applicant without varicella documentation: Either a titer or on-site Varivax administration at your civil surgeon exam, fitted into the same appointment.
Bring every immunization record you can find to your exam, even partial or decades-old ones. If you’re receiving other vaccines that day too, same-day coadministration is fine; separate live vaccines just need that 28-day gap if not given together.
Storage, Handling, and Why It Affects Your Appointment
Varivax and Shingrix are handled very differently behind the scenes, and that difference shapes how clinics schedule appointments. Varivax, as a live vaccine, has historically required frozen storage and needs to be reconstituted from a lyophilized (freeze-dried) powder just before injection, using its specific diluent. Once mixed, it has a short usable window and has to be given quickly or discarded.
Shingrix is a two-component system: a lyophilized antigen component and a separate adjuvant suspension, which get combined right before administration. It’s stored refrigerated rather than frozen, which makes inventory management somewhat simpler for clinics, though the reconstitution step still has to happen correctly and close to the time of injection.
Neither vaccine is something a clinic can pre-load hours in advance. This is one reason a well-run immigration medical exam schedules vaccine administration as part of the same visit as your civil surgeon exam, rather than treating it as an afterthought, since timing the reconstitution correctly takes coordination between the front desk and the clinical staff. A clinic juggling primary care, urgent care, and immigration exams in the same rooms has more moving parts to manage. A practice that only does immigration exams builds its whole day around getting this timing right the first time.
Does Getting One Vaccine Affect the Other?
There’s no cross-protection between Varivax and Shingrix. Immunity from a varicella vaccine or from having had chickenpox as a child does not extend to shingles protection later in life, and getting Shingrix does nothing to top up your varicella immunity. They work against the same virus at two completely different points in its behavior.
That said, there is an indirect connection worth understanding: shingles happens because the varicella zoster virus, after a chickenpox infection, goes dormant in nerve tissue and can reactivate years or decades later, usually when the immune system weakens with age or illness. Vaccination against chickenpox as a child doesn’t eliminate this risk later, since even a mild, vaccine-derived version of the virus can theoretically establish that same latency, though at meaningfully lower rates than natural infection.
As for interactions, Shingrix can generally be given alongside other adult vaccines, including flu shots, without a required spacing interval. The interaction that actually matters is the live-vaccine spacing rule: if Varivax isn’t given the same day as another live-virus vaccine, providers wait 28 days between them. Shingrix, being non-live, isn’t part of that restriction at all. If you’re catching up on multiple vaccines in the same visit for an I-693 exam, this is exactly the kind of detail an experienced civil surgeon sorts out for you rather than leaving to guesswork.
If You Already Had Chickenpox, Do You Still Need Shingrix?
Yes. Having had chickenpox as a child, or having been vaccinated against it, does not exclude you from the Shingrix recommendation later in life. In fact, it’s the opposite: a prior chickenpox infection is precisely what puts the virus into your nerve tissue in the first place, creating the shingles risk Shingrix is designed to reduce.
The CDC’s own guidance notes that screening for a history of chickenpox is not required or recommended before giving Shingrix. Most adults born in the United States before widespread varicella vaccination became routine in the 1990s were exposed to chickenpox naturally, whether or not they remember having symptoms. That population is squarely who the age-50-and-older Shingrix recommendation targets.
The one group where the calculation genuinely shifts is people vaccinated against chickenpox rather than naturally infected. Some research suggests vaccinated individuals may carry a somewhat lower shingles risk than those with natural infection, though the evidence base is still developing given how much more recent widespread childhood vaccination is. Current guidance doesn’t carve out an exception for this group. If you’re 50 or older, or younger with a qualifying immune condition, Shingrix still applies to you regardless of whether your original varicella immunity came from infection or from Varivax as a child.
Cost Considerations and Insurance Coverage
Cost is often what determines timing more than medical necessity does. Shingrix, for most insured adults 50 and older, is covered at no out-of-pocket cost under Affordable Care Act preventive care rules when received in-network, though Medicare Part D coverage varies by plan and sometimes still involves a copay. Without insurance, Shingrix can run into the hundreds of dollars for the full 2-dose series, since pricing varies significantly by pharmacy and provider.
Varivax coverage for children is broadly included under routine pediatric immunization schedules and is typically covered without cost sharing. For adults needing catch-up doses, coverage depends more heavily on the specific insurance plan, and pharmacy pricing can vary.
For immigration applicants specifically, the calculation looks a little different. A varicella titer blood test often costs somewhere in the range of $50 to $70, and in some cases that’s cheaper than paying for two doses of Varivax out of pocket if there’s a reasonable chance you already have immunity. A civil surgeon weighs that trade-off with you rather than defaulting straight to vaccination. Immigrationmedicalexams builds vaccination review, titer testing, and any needed vaccine administration into its exam process so applicants aren’t left guessing about what a missing record will cost them at the appointment.
How Long Does Protection Actually Last?
Varivax protection is durable for most recipients. Two-dose vaccination runs around 90% effective at preventing chickenpox entirely, and breakthrough cases in vaccinated people tend to be markedly milder than chickenpox in someone with no immunity at all. Long-term studies following vaccinated cohorts for decades continue to show sustained protection, though as with most vaccines, effectiveness isn’t identical to zero risk.
Shingrix effectiveness holds up well over time too, though it does gradually decline. Trial data showing roughly 97% efficacy in adults 50 to 69 reflects protection shortly after the 2-dose series. Effectiveness remains strong for at least several years afterward, which is a meaningful improvement over the older Zostavax vaccine, discontinued in the United States in 2020, which offered lower and shorter-lived protection by comparison.
Neither vaccine is described by health authorities as offering lifetime, absolute immunity. What the data supports is that both meaningfully cut your risk of the disease they target, and in Shingrix’s case, cut the risk of the long-term nerve pain that makes shingles particularly miserable for older adults.
Clinic Perspective: What We See Behind the Scenes
The most common problem we run into isn’t confusion about which vaccine does what. It’s applicants showing up without records, assuming a verbal history of chickenpox will satisfy USCIS. It won’t. Immigrationmedicalexams has specialized exclusively in I-693 exams since 2007, and resolving missing varicella documentation through a titer or on-site Varivax, correctly and in one visit, is something we handle routinely. Our flat-package pricing and 24/7 online scheduling exist specifically to prevent the kind of resubmission delays that come from getting this wrong the first time.
— ImmigrationMedicalExams Medical Team
Get Your I-693 Exam and Vaccine Review Done Right the First Time
If you’re staring at a USCIS deadline without a clear varicella immunity record, you don’t need to guess whether a titer, Varivax, or something else applies to you. Vaccination review, titer testing, and Varivax administration can often be done during the same appointment as a civil surgeon exam, helping prevent a missing record from causing a second visit or a rejected form.
We specialize exclusively in immigration medical exams and Form I-693. No primary care, no urgent care, no sick visits competing for the same appointment slots. Our flat-package pricing is built to avoid surprise costs, with standard processing in approximately 3 days and a 2-day expedited option when your timeline is tight. Bring any prior immunization records, even partial ones, and we’ll sort out what USCIS actually needs from there. Schedule your USCIS immigration medical exam online any time, day or night, and get your vaccination status and sealed I-693 handled in one visit instead of several.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Sources
- Varicella (Chickenpox) vaccine | CDC
- Shingles vaccine recommendations | CDC
- Shingles vaccination | CDC
FAQ
Should I Get the Varicella Vaccine or the Shingles Vaccine?
It depends entirely on your age and history, not personal preference. Children and adults with no evidence of chickenpox immunity need Varivax; adults 50 and older, or younger adults with qualifying immune conditions, need Shingrix for shingles prevention. Most people eventually need both at different points in life, not one instead of the other.
Can I Get Shingrix if I Never Had Chickenpox?
Yes. The CDC does not require screening for chickenpox history before administering Shingrix, and age or immune status, not chickenpox history, determines eligibility. If you’re unsure whether you ever had varicella and it matters for immigration paperwork, that’s a separate question best resolved with a titer test.
Was Zostavax Discontinued in the United States?
Yes, Zostavax was discontinued in the U.S. in November 2020 and fully replaced by Shingrix as the recommended shingles vaccine. Shingrix offers higher efficacy and is now the only shingles vaccine administered in the United States.
Are Shingrix and Varivax the Same Vaccine?
No, they are entirely different vaccines for different diseases. Varivax is a live vaccine preventing chickenpox, while Shingrix is a non-live, recombinant vaccine preventing shingles; neither can substitute for the other on medical or immigration paperwork.
Is Shingrix Necessary After Varivax?
Yes, if you’re 50 or older or meet the immunocompromised criteria, since prior Varivax vaccination doesn’t protect against shingles later in life. The two target completely different points in the varicella zoster virus’s behavior in the body.
Does Shingrix Satisfy USCIS Varicella Requirements for Form I-693?
No. USCIS requires documented evidence of varicella immunity specifically, and Shingrix does not establish that immunity under any circumstance. Applicants missing varicella records typically need a titer test or Varivax administration during their civil surgeon exam.